Literature DB >> 30518569

The Noncoding RNA nc886 Regulates PKR Signaling and Cytokine Production in Human Cells.

Ewelina Golec1, Liza Lind1, Munazza Qayyum1, Anna M Blom1, Ben C King2.   

Abstract

Protein kinase RNA-activated (PKR) is a cytoplasmic receptor for dsRNA, and as such is involved in detection of viral infection. On binding dsRNA, PKR dimerizes, autophosphorylates, and then phosphorylates its substrate, eukaryotic translation initiation factor 2 subunit α (eIF2α), causing inhibition of mRNA translation and shutdown of viral protein production. However, active PKR has also been found to be involved in the NF-κB signaling pathway by inducing phosphorylation of IκBα. PKR is regulated by the noncoding RNA nc886, which has altered expression in cancer. We have found that expression of nc886 is highly upregulated during activation of human CD4+ T cells. As has been described in other cell types, nc886 bound to PKR in human T cell lysates, preventing PKR phosphorylation by polyinosinic:polycytidylic acid or HIV trans-activation response element RNA in lysates of T cell lines or primary human CD4+ T cells. Using clonal human T cell lines, we found that nc886 expression was strictly required for IFN-γ and IL-2 expression and secretion after T cell activation but did not affect proliferation or activation-induced cell death. In stimulated human PBMCs, nc886 expression strongly correlated with IFN-γ expression. Although nc886 inhibited PKR activation by dsRNA, it was required for PKR phosphorylation during T cell stimulation, with subsequent NF-κB signaling and CREB phosphorylation. nc886 also regulated PKR phosphorylation during human monocyte-derived macrophage activation. We have therefore identified nc886 as a noncoding RNA marker of T cell activation and regulator of PKR-dependent signaling.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30518569     DOI: 10.4049/jimmunol.1701234

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  The nuclear and cytoplasmic activities of RNA polymerase III, and an evolving transcriptome for surveillance.

Authors:  Alan C Kessler; Richard J Maraia
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

2.  Activation of dsRNA-Dependent Protein Kinase R by miR-378 Sustains Metabolic Inflammation in Hepatic Insulin Resistance.

Authors:  Hao Wang; Yongyan Song; Yuxin Wu; Virender Kumar; Ram I Mahato; Qiaozhu Su
Journal:  Diabetes       Date:  2021-01-08       Impact factor: 9.461

3.  Noncoding RNA 886 alleviates tumor cellular immunological rejection in host C57BL/C mice.

Authors:  Hui Ma; Miao Wang; Ying Zhou; Jia-Jie Yang; Li-Yong Wang; Rong-Hui Yang; Min-Jie Wen; Lu Kong
Journal:  Cancer Med       Date:  2020-05-31       Impact factor: 4.452

4.  Inhibition of UVB-Induced Inflammation by Laminaria japonica Extract via Regulation of nc886-PKR Pathway.

Authors:  Kwang-Soo Lee; Eunae Cho; Jin Bae Weon; Deokhoon Park; Mathilde Fréchet; Hanane Chajra; Eunsun Jung
Journal:  Nutrients       Date:  2020-06-30       Impact factor: 5.717

5.  A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus.

Authors:  Enkhjin Saruuldalai; Jiyoung Park; Dongmin Kang; Seung-Phil Shin; Wonkyun Ronny Im; Hwi-Ho Lee; Jiyoung Joan Jang; Jong-Lyul Park; Seon-Young Kim; Jung-Ah Hwang; Young-Dong Kim; Jung-Hoon Lee; Eun Jung Park; Yeon-Su Lee; In-Hoo Kim; Sang-Jin Lee; Yong Sun Lee
Journal:  Mol Ther Oncolytics       Date:  2022-02-20       Impact factor: 7.200

6.  Long non-coding RNA DARS-AS1 promotes tumor progression by directly suppressing PACT-mediated cellular stress.

Authors:  Liuqing Yang; Kequan Lin; Lin Zhu; Huili Wang; Shuaishuai Teng; Lijun Huang; Shiyi Zhou; Guanbin Zhang; Zhi John Lu; Dong Wang
Journal:  Commun Biol       Date:  2022-08-15

7.  Double-stranded RNA induction asa potential dynamic biomarkerfor DNA-demethylating agents.

Authors:  Minjeong Kang; Raisa Kharbash; Ja Min Byun; Jaemin Jeon; Ahsan Ausaf Ali; Doyeong Ku; Jimin Yoon; Yongsuk Ku; Jooyeon Sohn; Seung-Jae V Lee; Dong-Yeop Shin; Youngil Koh; Sung-Soo Yoon; Junshik Hong; Yoosik Kim
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-21       Impact factor: 10.183

8.  VTRNA2-1: Genetic Variation, Heritable Methylation and Disease Association.

Authors:  Pierre-Antoine Dugué; Chenglong Yu; Timothy McKay; Ee Ming Wong; Jihoon Eric Joo; Helen Tsimiklis; Fleur Hammet; Maryam Mahmoodi; Derrick Theys; John L Hopper; Graham G Giles; Roger L Milne; Jason A Steen; James G Dowty; Tu Nguyen-Dumont; Melissa C Southey
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.